Improved Blood Sugar Management in Type 2 Diabetes To date, this course of drugs has shown considerable performance in the remedy of type two diabetes, dependant on outcomes of five randomized clinical trials cited through the FDA in its May well 2022 statement asserting the acceptance of tirzepatid